CA Stock MarketDetailed Quotes

TLT Theralase Technologies Inc

Watchlist
  • 0.250
  • +0.030+13.64%
15min DelayMarket Closed Dec 2 16:00 ET
61.94MMarket Cap-12500P/E (TTM)

About Theralase Technologies Inc Company

Theralase Technologies Inc is a clinical-stage pharmaceutical company. It is dedicated to the research and development of light-activated Photo Dynamic Compounds, their associated drug formulations, and technology platforms intended to safely and effectively; treat various cancers, bacteria, and viruses. The Cool Laser Technology division designs, develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the FDA for the healing of chronic knee pain and when used off-label for healing numerous nerve, muscle, and joint conditions. The ACT division conducts preclinical and clinical research and development for PDCs, in the treatment of cancer, with assistance from the CLT division to develop medical lasers to activate them.

Company Profile

SymbolTLT
Company NameTheralase Technologies Inc
Founded1989
MarketTSX
Employees14
Fiscal Year Ends12-31
Address41 Hollinger Road
CityToronto
CountryCAN
Zip CodeM4B 3G4
Phone+1 416 699-5273

Company Executives

  • Name
  • Position
  • Salary
  • Roger Dumoulin-White
  • President, Chief Executive Officer and Director
  • --
  • Dr. Arkady Mandel, M.D.,PhD
  • Director and Chief Scientific Officer
  • --
  • Kristina Hachey
  • Director; Chief Financial Officer of the Company and Theralase Inc
  • --
  • Matthew Perraton
  • Chairman of the Board
  • --
  • Dr. Kaouthar Lbiati, M.D.
  • Independent Director
  • --
  • Randy Bruder
  • Independent Director
  • --
  • Guy Anderson
  • Independent Director
  • --
Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data